Searchable abstracts of presentations at key conferences in endocrinology

ea0081rc4.5 | Rapid Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Validation of the ICD-codes for acromegaly – strategies to reduce false positive cases and improve estimation of the incidence in Sweden

Tsatsaris Erika , Robert Jonas , Berinder Katarina , Bonelli Lorenza , Burman Pia , Dahlqvist Per , Hoybye Charlotte , Ragnarsson Oskar , Vouzouneraki Konstantina , AEkerman Anna-Karin , Ekman Bertil , Eden Engstrom Britt

Purpose: We aimed to validate the diagnosis and estimated national incidence of acromegaly reported in the Swedish National Patient Register (NPR), based on clinically reported International Classification of Diseases (ICD-codes), in comparison with the Swedish Pituitary Register (SPR).Methods: All patients in NPR or SPR between 1991-2018 with the ICD-9 or ICD-10 diagnosis of acromegaly and age >18 years at diagnosis were included. The diagnosis was ...

ea0099oc5.3 | Oral Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Transcriptomics analysis confirms WHO classification of PitNETs and reveals distinct patterns related to invasiveness

Jotanovic Jelena , Tebani Abdellah , Hekmati Neda , Sivertsson AEsa , Lindskog Cecilia , Uhlen Mathias , Gudjonsson Olafur , Tsatsaris Erika , Eden Engstrom Britt , Wikstrom Johan , Ponten Fredrik , Casar-Borota Olivera

Pituitary neuroendocrine tumors (PitNETs) are typically benign tumors presenting with symptoms related to hormone hypersecretion and/or intracranial mass. Current classification of PitNETs is based on the immunohistochemical expression of adenohypophysial hormones and three main pituitary-specific transcriptions factors PIT1, TPIT and SF1. PitNETs usually remain intrasellar, however, 20-40% of tumors show invasiveness into cavernous sinus and 6–8% infiltrate into the bone...